• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝X受体激动剂T0901317对内皮素-1诱导的小鼠HL-1心肌细胞肥大的影响

[Effect of liver X receptor agonist T0901317 on endothelin-1 induced murine HL-1 cardiomyocytes hypertrophy].

作者信息

Li Jiang, Deng Chun, Gu Wen-juan, Nie Sai, Peng Dao-quan, Zhao Shui-ping

机构信息

Department of Cardiology, Central South University, Changsha, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Feb;40(2):161-5.

PMID:22490719
Abstract

OBJECTIVE

To investigate the role of liver X receptors (LXRs) on endothelin-1 (ET-1) induced murine HL-1 cardiomyocytes hypertrophy.

METHODS

Cultured murine HL-1 cardiomyocytes were divided into four experiment groups: (1) CONTROL GROUP:treated with DMSO; (2) T0901317 group:treated with LXRs agonist T0901317 (1 µmol/L); (3) ET-1 group:treated with ET-1 (1 nmol/L); (4) T0901317 + ET-1 group:treated with T0901317 (1 µmol/L) for 8 hours, then treated with ET-1 (1 nmol/L). Twenty-four hours later, immunofluorescent staining was performed on HL-1 cells, the surface area of HL-1 cells was analyzed with NIH Image J software, and the synthetic rate of protein in HL-1 cells was detected by (3)H-leucine incorporation. The mRNA level of atrial natriuretic peptide (ANP) and β-myosin heavy chain (β-MyHC) was measured by quantitative realtime PCR. The effect of T0901317 on mRNA expression of ANP was also detected after LXRs gene silencing.

RESULTS

The surface area of HL-1 cells, mRNA expression of ANP and β-MyHC, and (3)H-leucine incorporation in ET-1 group were 2.00 ± 0.29, 1.98 ± 0.47, 2.13 ± 0.39 and 1.79 ± 0.17, respectively, which were significantly higher than those of control group (1.00 ± 0.26, 1.00 ± 0.21, 1.00 ± 0.31 and 1.00 ± 0.03, respectively, all P < 0.05). Compared with ET-1 group, the surface area of HL-1 cells, mRNA expression of ANP and β-MyHC, and (3)H-leucine incorporation were significantly decreased in T0901317 + ET-1 group (1.24 ± 0.25, 1.19 ± 0.21, 1.48 ± 0.27 and 1.15 ± 0.11, respectively, all P < 0.05). After inhibition of LXRα/β expression in HL-1 cardiomyocytes using the specific siRNAs, the mRNA expression of ANP in T0901317 + ET-1 group was 1.78 ± 0.05, which was similar as that in ET-1 group (1.94 ± 0.17, P > 0.05).

CONCLUSION

T0901317, an agonist of LXRs, could inhibit ET-1 induced cardiac hypertrophy in vitro, and LXR ligand-mediated inhibition on ANP mRNA expression by T0901317 is receptor dependent.

摘要

目的

研究肝脏X受体(LXRs)在内皮素-1(ET-1)诱导的小鼠HL-1心肌细胞肥大中的作用。

方法

将培养的小鼠HL-1心肌细胞分为4个实验组:(1)对照组:用二甲基亚砜(DMSO)处理;(2)T0901317组:用LXRs激动剂T0901317(1 μmol/L)处理;(3)ET-1组:用ET-1(1 nmol/L)处理;(4)T0901317 + ET-1组:先用T0901317(1 μmol/L)处理8小时,然后用ET-1(1 nmol/L)处理。24小时后,对HL-1细胞进行免疫荧光染色,用NIH Image J软件分析HL-1细胞的表面积,通过³H-亮氨酸掺入法检测HL-1细胞中的蛋白质合成率。用定量实时聚合酶链反应检测心钠素(ANP)和β-肌球蛋白重链(β-MyHC)的mRNA水平。在LXRs基因沉默后,也检测了T0901317对ANP mRNA表达的影响。

结果

ET-1组HL-1细胞的表面积、ANP和β-MyHC的mRNA表达以及³H-亮氨酸掺入率分别为2.00±0.29、1.98±0.47、2.13±0.39和1.79±0.17,均显著高于对照组(分别为1.00±0.26、1.00±0.21、1.00±0.31和1.00±0.03,均P<0.05)。与ET-1组相比,T0901317 + ET-1组HL-1细胞的表面积、ANP和β-MyHC的mRNA表达以及³H-亮氨酸掺入率均显著降低(分别为1.24±0.25、1.19±0.21、1.48±0.27和1.15±0.11,均P<0.05)。用特异性小干扰RNA(siRNAs)抑制HL-1心肌细胞中LXRα/β的表达后,T0901317 + ET-1组中ANP的mRNA表达为1.78±0.05,与ET-1组(1.94±0.17)相似(P>0.05)。

结论

LXRs激动剂T0901317可在体外抑制ET-1诱导的心肌肥大,且T0901317通过LXR配体介导的对ANP mRNA表达的抑制作用是受体依赖性的。

相似文献

1
[Effect of liver X receptor agonist T0901317 on endothelin-1 induced murine HL-1 cardiomyocytes hypertrophy].肝X受体激动剂T0901317对内皮素-1诱导的小鼠HL-1心肌细胞肥大的影响
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Feb;40(2):161-5.
2
[Role of liver X receptors on cardiomyocyte hypertrophy].
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Dec;37(12):1119-23.
3
Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.肝 X 受体激动剂甲基-3β-羟基-5α,6α-环氧胆甾烷酸可降低载脂蛋白 E 基因敲除小鼠的动脉粥样硬化,而不增加血浆甘油三酯。
Pharmacology. 2010;86(5-6):306-12. doi: 10.1159/000321320. Epub 2010 Nov 10.
4
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.用 T0901317 激活肝 X 受体可减轻体内心肌肥厚。
Eur J Heart Fail. 2010 Oct;12(10):1042-50. doi: 10.1093/eurjhf/hfq109. Epub 2010 Jun 29.
5
Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.肝脏X受体激活对脂肪组织中胰岛素抵抗和脂联素信号的调节突出了与过氧化物酶体增殖物激活受体γ的相互作用。
PLoS One. 2014 Jun 27;9(6):e101269. doi: 10.1371/journal.pone.0101269. eCollection 2014.
6
Association between liver X receptor-α and neuron-derived orphan nuclear receptor-1 in Kupffer cells of C57BL/6 mice during inflammation.C57BL/6小鼠炎症期间库普弗细胞中肝脏X受体-α与神经元衍生孤儿核受体-1之间的关联
Mol Med Rep. 2015 Oct;12(4):6098-104. doi: 10.3892/mmr.2015.4155. Epub 2015 Jul 30.
7
Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.不同浓度的 T0901317(肝 X 受体激动剂)对鸡原代肝细胞中胆汁酸、胆固醇和脂肪酸合成的调控。
Comp Biochem Physiol A Mol Integr Physiol. 2011 Feb;158(2):201-6. doi: 10.1016/j.cbpa.2010.10.028. Epub 2010 Nov 3.
8
Synthetic liver X receptor agonist T0901317 attenuates high glucose-induced oxidative stress, mitochondrial damage and apoptosis in cardiomyocytes.合成型肝脏X受体激动剂T0901317减轻高糖诱导的心肌细胞氧化应激、线粒体损伤和细胞凋亡。
Acta Histochem. 2014 Jan;116(1):214-21. doi: 10.1016/j.acthis.2013.07.007. Epub 2013 Jul 31.
9
Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate.软脂酸诱导的胰腺β细胞凋亡可被肝 X 受体激动剂增强,并被二十碳五烯酸减弱。
In Vivo. 2011 Sep-Oct;25(5):711-8.
10
LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.配体激动剂改善 TNF-α 诱导的内皮功能障碍,而不影响其胆固醇调节作用。
Atherosclerosis. 2014 Jan;232(1):1-9. doi: 10.1016/j.atherosclerosis.2013.10.001. Epub 2013 Oct 26.